4 views left Get unlimited views with a free account

Take your business to the next level. Explore the latest trends and actionable insights to inform business strategy and pinpoint opportunities and risks.

Number of ongoing Clinical Trials (for drugs) involving Metabolic Syndrome by Phase

Industry: Pharmaceuticals
Current: Other Industry Indicators

There are currently 142 ongoing clinical trials involving Metabolic Syndrome
Of the 142 trials,85 trials are in Phase II
Furthermore, 18 trials are in Phase IV

Number of ongoing Clinical Trials (for drugs) involving Metabolic Syndrome by Phase

View as table

The global pharmaceutical industry is steadily developing new drugs for Metabolic Syndrome, a Metabolic Disorder condition. The largest number of ongoing clinical trials for Metabolic Syndrome is conducted in the Asia-Pacific region. North America and Europe are among some of the other prominent regions engaged in Metabolic Syndrome-related drug trials.

Isfahan University of Medical Sciences: The leading ongoing Metabolic Syndrome related clinical trial sponsor

Isfahan University of Medical Sciences is the top sponsor for Metabolic Syndrome-related ongoing clinical trials.

University of Guadalajara, Academic Medical Center, National Nutrition and Food Technology Research Institute and Amsterdam University Medical Center are among other notable clinical trial sponsors involved in Metabolic Syndrome. A clinical trial sponsor can be a Company, Government, Individual, or Institution.